Skip Navigation


Hum. Reprod. Advance Access originally published online on June 3, 2006
Human Reproduction 2006 21(9):2290-2295; doi:10.1093/humrep/del194
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/9/2290    most recent
del194v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Artama, M.
Right arrow Articles by Auvinen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artama, M.
Right arrow Articles by Auvinen, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Antiepileptic drug use and birth rate in patients with epilepsy—a population-based cohort study in Finland

Miia Artama1,4, J.I.T. Isojärvi2,5 and A. Auvinen1,3

1 School of Public Health, University of Tampere, Tampere 2 Department of Neurology, University of Oulu, Oulu and 3 Pediatric Research Centre, Tampere University Hospital, Tampere, Finland

4 To whom correspondence should be addressed at: Tampere School of Public Health, University of Tampere, Tampere 33014, Finland. E-mail: miia.artama{at}uta.fi

5 Address during the study: GlaxoSmithKline, Neurosciences MDC, Research Triangle Park, NC 27709, USA

BACKGROUND: Antiepileptic medication use affects reproductive endocrine function, but its impact on fertility is not well known. METHODS: All epilepsy patients, who were approved as being eligible for reimbursement for antiepileptic drug (AED) costs from the Social Insurance Institution (SII) of Finland for the first time 1985–94, were identified from the SII database. A reference cohort without epilepsy was identified from the Finnish Population Register Centre. Information on AED purchases 1996–2000 was obtained from the SII database through computerized record linkage with the unique personal identification number assigned to all residents of Finland. The three AEDs included were carbamazepine, oxcarbazepine (OXC) and valproate. RESULTS: Birth rate was lower in both men and women with epilepsy on AEDs than in the reference cohort without epilepsy. However, compared with patients not using AED during the study period, the birth rate was lowered only among men on OXC [rate ratio (RR) = 0.52, 95% confidence interval (CI) = 0.32, 0.84]. CONCLUSIONS: The birth rate was lower in both women and men on any of the three AEDs compared with the reference cohort without epilepsy. However, a statistically significant difference between treated and untreated patients was only seen in men on OXC. It is unclear to what extent the differences found in this study are due to social or biological factors.

Key words: antiepileptic drug/birth rate/cohort study/epilepsy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. A. Krusche, A. J. Vloet, I. Classen-Linke, U. von Rango, H. M. Beier, and J. Alfer
Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas
Hum. Reprod., November 1, 2007; 22(11): 2956 - 2966.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.